Conversely, the levels of the tumor suppressors (e.g., DAPK1, TIMP3, GRIN2B, SLC5A8, and CDH1) are low in the gastric tissues of patients with gastric cancer (George et al., 2020). This evidence concerns the gene CDH1 and gastric cancer.